XML 85 R69.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Financial Information (Details 4) (USD $)
In Thousands, unless otherwise specified
 0 Months Ended 9 Months Ended
Aug. 18, 2014
May 16, 2014
Mar. 28, 2014
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:          
Net cash provided by (used in) continuing operations       $ 276,168 $ 222,184
Net cash provided by discontinued operations       3,954 6,054
Net cash provided by operating activities       280,122 228,238
Cash flows from investing activities:          
Capital expenditures       (385,739) (307,863)
Proceeds from sale of property, plant and equipment       19,736 83,978
Payments for MidCon acquisitions       (494,755)  
Increase in restricted cash       (245)  
Return of investments in non-consolidated affiliates       14,750 14,165
Cash invested in non-consolidated affiliates       (197)  
Net cash used in continuing operations       (846,450) (209,720)
Net cash provided by discontinued operations       49,835 58,449
Net cash used in investing activities       (796,615) (151,271)
Cash flows from financing activities:          
Proceeds from borrowings of long-term debt       1,849,799 1,778,037
Repayments of long-term debt       (1,406,000) (1,796,250)
Payments for debt issuance costs       (6,923) (11,929)
Payments above face value for redemption of convertible debt       (15,007)  
Payments for settlement of interest rate swaps that include financing elements       (2,844) (1,271)
Net proceeds from the sale of Partnership units       169,471  
Proceeds from stock options exercised       11,637 5,975
Proceeds from stock issued pursuant to our employee stock purchase plan       1,324 1,213
Purchases of treasury stock       (6,372) (3,594)
Dividends to Exterran stockholders (10,000) (10,000) (10,000) (30,047)  
Stock-based compensation excess tax benefit       8,269 1,075
Distributions to noncontrolling partners in the Partnership       (54,893) (46,244)
Net cash provided by (used in) financing activities       518,414 (72,988)
Effect of exchange rate changes on cash and cash equivalents       (3,797) (1,516)
Net increase (decrease) in cash and cash equivalents       (1,876) 2,463
Cash and cash equivalents at beginning of period       35,665 34,601
Cash and cash equivalents at end of period       33,789 37,064
Eliminations
          
Cash flows from investing activities:          
Capital expenditures         3,378
Proceeds from sale of property, plant and equipment         (3,378)
Capital distributions received from consolidated subsidiaries       (40,688) (32,612)
Investment in consolidated subsidiaries       13,813 16,830
Return of investments in consolidated subsidiaries       (252,482)  
Net cash used in continuing operations       (279,357) (15,782)
Net cash used in investing activities       (279,357) (15,782)
Cash flows from financing activities:          
Distributions to noncontrolling partners in the Partnership       40,688 32,612
Net proceeds from sale of general partner units       (3,573)  
Capital distributions to affiliates       252,482  
Capital contributions received from parent       (10,240) (16,830)
Net cash provided by (used in) financing activities       279,357 15,782
Parent | Reportable Legal Entities
          
Cash flows from operating activities:          
Net cash provided by (used in) continuing operations       (1,743) 6,301
Net cash provided by operating activities       (1,743) 6,301
Cash flows from investing activities:          
Return of investments in consolidated subsidiaries       252,482  
Net cash used in continuing operations       252,482  
Net cash used in investing activities       252,482  
Cash flows from financing activities:          
Proceeds from borrowings of long-term debt       1,056,001 854,501
Repayments of long-term debt       (1,073,500) (911,750)
Payments above face value for redemption of convertible debt       (15,007)  
Proceeds from stock options exercised       11,637 5,975
Proceeds from stock issued pursuant to our employee stock purchase plan       1,324 1,213
Purchases of treasury stock       (6,372) (3,594)
Dividends to Exterran stockholders       (30,047)  
Stock-based compensation excess tax benefit       8,269 1,075
Borrowings (repayments) between consolidated subsidiaries, net       (203,025) 46,272
Net cash provided by (used in) financing activities       (250,720) (6,308)
Net increase (decrease) in cash and cash equivalents       19 (7)
Cash and cash equivalents at beginning of period       11 24
Cash and cash equivalents at end of period       30 17
Guarantor Subsidiaries | Reportable Legal Entities
          
Cash flows from operating activities:          
Net cash provided by (used in) continuing operations       79,455 117,958
Net cash provided by operating activities       79,455 117,958
Cash flows from investing activities:          
Capital expenditures       (116,458) (143,823)
Proceeds from sale of property, plant and equipment       8,274 21,475
Payments for MidCon acquisitions       (11,743)  
Capital distributions received from consolidated subsidiaries       40,688 32,612
Investment in consolidated subsidiaries       (13,813) (16,830)
Net cash used in continuing operations       (93,052) (106,566)
Net cash used in investing activities       (93,052) (106,566)
Cash flows from financing activities:          
Capital distributions to affiliates       (252,482)  
Borrowings (repayments) between consolidated subsidiaries, net       264,974 (17,339)
Net cash provided by (used in) financing activities       12,492 (17,339)
Net increase (decrease) in cash and cash equivalents       (1,105) (5,947)
Cash and cash equivalents at beginning of period       1,554 10,461
Cash and cash equivalents at end of period       449 4,514
Other Subsidiaries | Reportable Legal Entities
          
Cash flows from operating activities:          
Net cash provided by (used in) continuing operations       198,456 97,925
Net cash provided by discontinued operations       3,954 6,054
Net cash provided by operating activities       202,410 103,979
Cash flows from investing activities:          
Capital expenditures       (269,281) (167,418)
Proceeds from sale of property, plant and equipment       11,462 65,881
Payments for MidCon acquisitions       (483,012)  
Increase in restricted cash       (245)  
Return of investments in non-consolidated affiliates       14,750 14,165
Cash invested in non-consolidated affiliates       (197)  
Net cash used in continuing operations       (726,523) (87,372)
Net cash provided by discontinued operations       49,835 58,449
Net cash used in investing activities       (676,688) (28,923)
Cash flows from financing activities:          
Proceeds from borrowings of long-term debt       793,798 923,536
Repayments of long-term debt       (332,500) (884,500)
Payments for debt issuance costs       (6,923) (11,929)
Payments for settlement of interest rate swaps that include financing elements       (2,844) (1,271)
Net proceeds from the sale of Partnership units       169,471  
Distributions to noncontrolling partners in the Partnership       (95,581) (78,856)
Net proceeds from sale of general partner units       3,573  
Capital contributions received from parent       10,240 16,830
Borrowings (repayments) between consolidated subsidiaries, net       (61,949) (28,933)
Net cash provided by (used in) financing activities       477,285 (65,123)
Effect of exchange rate changes on cash and cash equivalents       (3,797) (1,516)
Net increase (decrease) in cash and cash equivalents       (790) 8,417
Cash and cash equivalents at beginning of period       34,100 24,116
Cash and cash equivalents at end of period       $ 33,310 $ 32,533